Global Nuclear Medicine/Radiopharmaceuticals Market 2020 by Manufacturers, Type and Application, Forecast to 2025

  • receipt Report ID : 91265
  • calendar_today Published On: Aug, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The Nuclear Medicine/Radiopharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Nuclear Medicine/Radiopharmaceuticals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.8%% in the forecast period of 2020 to 2025 and will expected to reach USD 7558.2 million by 2025, from USD 5593 million in 2019.

Market segmentation

Nuclear Medicine/Radiopharmaceuticals market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Nuclear Medicine/Radiopharmaceuticals market has been segmented into Diagnostic, Therapeutic, etc.

Breakdown by Application, Nuclear Medicine/Radiopharmaceuticals has been segmented into Oncology, Thyroid, Cardiology, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Nuclear Medicine/Radiopharmaceuticals market presented in the report. This section sheds light on the sales growth of different regional and country-level Nuclear Medicine/Radiopharmaceuticals markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nuclear Medicine/Radiopharmaceuticals market.

For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Nuclear Medicine/Radiopharmaceuticals Market Share Analysis

Nuclear Medicine/Radiopharmaceuticals competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Nuclear Medicine/Radiopharmaceuticals sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nuclear Medicine/Radiopharmaceuticals sales, revenue and market share for each player covered in this report.

The major players covered in Nuclear Medicine/Radiopharmaceuticals are: China Isotope & Radiation, Ciaeriar, Dongcheng, Jaco, Shanghai Atom Kexing, Advanced Molecular-imaging Solution, etc. Among other players domestic and global, Nuclear Medicine/Radiopharmaceuticals market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The key market players for global Nuclear Medicine/Radiopharmaceuticals market are listed below:

China Isotope & Radiation

Ciaeriar

Dongcheng

Jaco

Shanghai Atom Kexing

Advanced Molecular-imaging Solution

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

Market segment by Type, covers:

Diagnostic

Therapeutic

Market segment by Application, can be divided into

Oncology

Thyroid

Cardiology

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Nuclear Medicine/Radiopharmaceuticals Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Diagnostic

1.2.3 Therapeutic

1.3 Market Analysis by Application

1.3.1 Overview: Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Oncology

1.3.3 Thyroid

1.3.4 Cardiology

1.4 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast (2015-2025)

1.4.2 Global Nuclear Medicine/Radiopharmaceuticals Sales and Forecast (2015-2025)

1.5 Global Nuclear Medicine/Radiopharmaceuticals Market Size Overview by Geography (2015-2020)

2 Manufacturers Profiles

2.1 China Isotope & Radiation

2.1.1 China Isotope & Radiation Details

2.1.2 China Isotope & Radiation Major Business

2.1.3 China Isotope & Radiation SWOT Analysis

2.1.4 China Isotope & Radiation Product and Services

2.1.5 China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Ciaeriar

2.2.1 Ciaeriar Details

2.2.2 Ciaeriar Major Business

2.2.3 Ciaeriar SWOT Analysis

2.2.4 Ciaeriar Product and Services

2.2.5 Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Dongcheng

2.3.1 Dongcheng Details

2.3.2 Dongcheng Major Business

2.3.3 Dongcheng SWOT Analysis

2.3.4 Dongcheng Product and Services

2.3.5 Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 Jaco

2.4.1 Jaco Details

2.4.2 Jaco Major Business

2.4.3 Jaco SWOT Analysis

2.4.4 Jaco Product and Services

2.4.5 Jaco Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 Shanghai Atom Kexing

2.5.1 Shanghai Atom Kexing Details

2.5.2 Shanghai Atom Kexing Major Business

2.5.3 Shanghai Atom Kexing SWOT Analysis

2.5.4 Shanghai Atom Kexing Product and Services

2.5.5 Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Advanced Molecular-imaging Solution

2.6.1 Advanced Molecular-imaging Solution Details

2.6.2 Advanced Molecular-imaging Solution Major Business

2.6.3 Advanced Molecular-imaging Solution Product and Services

2.6.4 Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Global Nuclear Medicine/Radiopharmaceuticals Market, Company Landscape

3.1 Company Market Share Analysis: Global

3.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Manufacturer (2018-2019)

3.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Manufacturer (2018-2019)

3.2 Company Market Share Analysis: United States

3.2.1 Key Players Nuclear Medicine/Radiopharmaceuticals Sales in United States (2018-2019)

3.2.2 United States Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share in 2019

3.3.2 Top 6 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share in 2019

4 Market Size by Geography

4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Geography (2015-2020)

4.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Geography (2015-2020)

4.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions (2015-2020)

4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Regions (2020-2025)

4.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Forecast by Regions (2020-2025)

4.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast by Regions (2020-2025)

4.3 North America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

4.4 Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

4.5 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

4.6 South America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

4.7 Middle East and Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

5 North America by Country

5.1 North America Nuclear Medicine/Radiopharmaceuticals Market Size by Country (2015-2020)

5.1.1 North America Nuclear Medicine/Radiopharmaceuticals Sales and Market Share by Country (2015-2020)

5.1.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue and Market Share by Country (2015-2020)

5.2 North America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Country (2020-2025)

5.2.1 North America Nuclear Medicine/Radiopharmaceuticals Sales and Forecast by Country (2020-2025)

5.2.2 North America Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast by Country (2020-2025)

5.3 United States Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

5.4 Canada Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

5.5 Mexico Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

6 Europe by Country

6.1 Europe Nuclear Medicine/Radiopharmaceuticals Market Size by Country (2015-2020)

6.1.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020)

6.1.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020)

6.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Country (2020-2025)

6.2.1 Europe Nuclear Medicine/Radiopharmaceuticals Sales and Forecast by Country (2020-2025)

6.2.2 Europe Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast by Country (2020-2025)

6.3 Germany Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

6.4 United Kingdom Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

6.5 France Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

6.6 Russia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

6.7 Italy Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Size by Region (2015-2020)

7.1.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Region (2015-2020)

7.1.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Region (2015-2020)

7.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Region (2020-2025)

7.2.1 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales and Forecast by Region (2020-2025)

7.2.2 Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast by Region (2020-2025)

7.3 China Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

7.4 Japan Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

7.5 Korea Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

7.6 India Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

7.7 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

7.8 Australia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

8 South America by Country

8.1 South America Nuclear Medicine/Radiopharmaceuticals Market Size by Country (2015-2020)

8.1.1 South America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020)

8.1.2 South America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020)

8.2 South America Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Country (2020-2025)

8.2.1 South America Nuclear Medicine/Radiopharmaceuticals Sales and Forecast by Country (2020-2025)

8.2.2 South America Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast by Country (2020-2025)

8.3 Brazil Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

8.4 Argentina Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Size by Country (2015-2020)

9.1.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2015-2020)

9.1.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2015-2020)

9.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Country (2020-2025)

9.2.1 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales and Forecast by Country (2020-2025)

9.2.2 Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast by Country (2020-2025)

9.3 Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

9.4 Turkey Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

9.5 Egypt Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

9.6 South Africa Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast (2015-2025)

10 Market Segment by Type

10.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2020)

10.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020)

10.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2015-2020)

10.1.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Type (2015-2020)

10.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Type (2020-2025)

10.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Forecast by Type (2020-2025)

10.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast by Type (2020-2025)

10.2.3 Global Nuclear Medicine/Radiopharmaceuticals Price and Forecast by Type (2020-2025)

10.3 United States Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Type (2015-2025)

10.3.1 United States Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2015-2020)

10.3.2 United States Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Type (2020-2025)

11 Market Segment by Application

11.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2020)

11.1.1 Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020)

11.1.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2015-2020)

11.1.3 Global Nuclear Medicine/Radiopharmaceuticals Price by Application (2015-2020)

11.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Application (2020-2025)

11.2.1 Global Nuclear Medicine/Radiopharmaceuticals Sales and Forecast by Application (2020-2025)

11.2.2 Global Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast by Application (2020-2025)

11.2.3 Global Nuclear Medicine/Radiopharmaceuticals Price and Forecast by Application (2020-2025)

11.3 United States Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Application (2015-2025)

11.3.1 United States Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2015-2020)

11.3.2 United States Nuclear Medicine/Radiopharmaceuticals Market Size and Forecast by Application (2020-2025)

12 Sales Channel, Distributors, Costumers, and Market Dynamics

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Distributors, Traders and Dealers

12.4.1 Market Opportunities

12.4.2 Market Risk

12.4.3 Market Driving Force

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global Nuclear Medicine/Radiopharmaceuticals Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Nuclear Medicine/Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Nuclear Medicine/Radiopharmaceuticals Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global Nuclear Medicine/Radiopharmaceuticals Market Size Overview by Geography (2015-2020) (USD Million)

Table 5. Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. China Isotope & Radiation Basic Information, Manufacturing Base and Competitors

Table 7. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Major Business

Table 8. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)

Table 9. China Isotope & Radiation SWOT Analysis

Table 10. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Product and Services

Table 11. China Isotope & Radiation Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 12. Ciaeriar Basic Information, Manufacturing Base and Competitors

Table 13. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Major Business

Table 14. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)

Table 15. Ciaeriar SWOT Analysis

Table 16. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Product and Services

Table 17. Ciaeriar Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 18. Dongcheng Basic Information, Manufacturing Base and Competitors

Table 19. Dongcheng Nuclear Medicine/Radiopharmaceuticals Major Business

Table 20. Dongcheng Nuclear Medicine/Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)

Table 21. Dongcheng SWOT Analysis

Table 22. Dongcheng Nuclear Medicine/Radiopharmaceuticals Product and Services

Table 23. Dongcheng Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 24. Jaco Basic Information, Manufacturing Base and Competitors

Table 25. Jaco Nuclear Medicine/Radiopharmaceuticals Major Business

Table 26. Jaco Nuclear Medicine/Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)

Table 27. Jaco SWOT Analysis

Table 28. Jaco Nuclear Medicine/Radiopharmaceuticals Product and Services

Table 29. Jaco Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 30. Shanghai Atom Kexing Basic Information, Manufacturing Base and Competitors

Table 31. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Major Business

Table 32. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)

Table 33. Shanghai Atom Kexing SWOT Analysis

Table 34. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Product and Services

Table 35. Shanghai Atom Kexing Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 36. Advanced Molecular-imaging Solution Basic Information, Manufacturing Base and Competitors

Table 37. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Major Business

Table 38. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Total Revenue (USD Million) (2018-2019)

Table 39. Advanced Molecular-imaging Solution SWOT Analysis

Table 40. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Product and Services

Table 41. Advanced Molecular-imaging Solution Nuclear Medicine/Radiopharmaceuticals Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 42. Global Nuclear Medicine/Radiopharmaceuticals Sales by Manufacturer (2018-2019) (K Units)

Table 43. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Manufacturer (2018-2019) (USD Million)

Table 44. Key Players Nuclear Medicine/Radiopharmaceuticals Sales in United States (2018-2019) (K Units)

Table 45. Key Players Nuclear Medicine/Radiopharmaceuticals Sales Market Share in United States (2018-2019)

Table 46. Key Players Revenue of Nuclear Medicine/Radiopharmaceuticals in United States (2018-2019) (USD Million)

Table 47. Global Nuclear Medicine/Radiopharmaceuticals Sales by Regions (2015-2020) (K Units)

Table 48. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions (2015-2020)

Table 49. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Regions (2015-2020) (USD Million)

Table 50. Global Nuclear Medicine/Radiopharmaceuticals Sales and Forecast by Regions (2020-2025) (K Units)

Table 51. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Regions (2020-2025)

Table 52. Global Nuclear Medicine/Radiopharmaceuticals Revenue and Forecast by Regions (2020-2025) (USD Million)

Table 53. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions (2020-2025) (USD Million)

Table 54. North America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)

Table 55. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table 56. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)

Table 57. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Table 58. North America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2020-2025) (K Units)

Table 59. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2020-2025)

Table 60. North America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2020-2025) (USD Million)

Table 61. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2020-2025)

Table 62. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)

Table 63. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table 64. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)

Table 65. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Table 66. Europe Nuclear Medicine/Radiopharmaceuticals Sales by Country (2020-2025) (K Units)

Table 67. Europe Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2020-2025)

Table 68. Europe Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2020-2025) (USD Million)

Table 69. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2020-2025)

Table 70. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)

Table 71. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table 72. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)

Table 73. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Table 74. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales by Country (2020-2025) (K Units)

Table 75. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2020-2025)

Table 76. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2020-2025) (USD Million)

Table 77. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2020-2025)

Table 78. South America Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)

Table 79. South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table 80. South America Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)

Table 81. South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Table 82. South America Nuclear Medicine/Radiopharmaceuticals Sales by Country (2020-2025) (K Units)

Table 83. South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2020-2025)

Table 84. South America Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2020-2025) (USD Million)

Table 85. South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2020-2025)

Table 86. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Countries (2015-2020) (K Units)

Table 87. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Countries (2015-2020)

Table 88. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Countries (2015-2020) (USD Million)

Table 89. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Countries (2015-2020)

Table 90. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales by Country (2020-2025) (K Units)

Table 91. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country (2020-2025)

Table 92. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue by Country (2020-2025) (USD Million)

Table 93. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country (2020-2025)

Table 94. United States Nuclear Medicine/Radiopharmaceuticals Sales by Type (2015-2020) (K Units)

Table 95. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2015-2020)

Table 96. United States Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2015-2020) (USD Million)

Table 97. United States Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2015-2020)

Table 98. United States Nuclear Medicine/Radiopharmaceuticals Sales by Type (2020-2025) (K Units)

Table 99. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Type (2020-2025)

Table 100. United States Nuclear Medicine/Radiopharmaceuticals Revenue by Type (2020-2025) (USD Million)

Table 101. United States Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Type (2020-2025)

Table 102. Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)

Table 103. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)

Table 104. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2015-2020) (USD Million)

Table 105. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2015-2020)

Table 106. Global Nuclear Medicine/Radiopharmaceuticals Price by Application (2015-2020) (USD/Unit)

Table 107. Global Nuclear Medicine/Radiopharmaceuticals Sales by Application (2020-2025) (K Units)

Table 108. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2020-2025)

Table 109. Global Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2020-2025) (USD Million)

Table 110. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2020-2025)

Table 111. Global Nuclear Medicine/Radiopharmaceuticals Price by Application (2020-2025) (USD/Unit)

Table 112. United States Nuclear Medicine/Radiopharmaceuticals Sales by Application (2015-2020) (K Units)

Table 113. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2015-2020)

Table 114. United States Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2015-2020) (USD Million)

Table 115. United States Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2015-2020)

Table 116. United States Nuclear Medicine/Radiopharmaceuticals Sales by Application (2020-2025) (K Units)

Table 117. United States Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application (2020-2025)

Table 118. United States Nuclear Medicine/Radiopharmaceuticals Revenue by Application (2020-2025) (USD Million)

Table 119. United States Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Application (2020-2025)

Table 120. Direct Channel Pros & Cons

Table 121. Indirect Channel Pros & Cons

Table 122. Distributors/Traders/ Dealers List

Table 123. Customers of Nuclear Medicine/Radiopharmaceuticals

Table 124. Market Opportunities in Next Few Years

Table 125. Market Risks Analysis

Table 126. Market Drivers

List of Figures

Figure 1. Nuclear Medicine/Radiopharmaceuticals Picture

Figure 2. Global Nuclear Medicine/Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. Diagnostic Picture

Figure 4. Therapeutic Picture

Figure 5. Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Application in 2019

Figure 6. Oncology Picture

Figure 7. Thyroid Picture

Figure 8. Cardiology Picture

Figure 9. Global Nuclear Medicine/Radiopharmaceuticals Market Status and Outlook (2015-2025) (USD Million)

Figure 10. Global Nuclear Medicine/Radiopharmaceuticals Sales Growth Rate (2015-2025) (K Units)

Figure 11. Global Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Manufacturer in 2019

Figure 12. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Manufacturer in 2019

Figure 13. Key Players Nuclear Medicine/Radiopharmaceuticals Revenue Market Share in United States in 2019

Figure 14. Global Top 5 Nuclear Medicine/Radiopharmaceuticals Manufacturer Market Share in 2019

Figure 15. Top 3 Nuclear Medicine/Radiopharmaceuticals Players Market Share in United States in 2019

Figure 16. Global Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Regions in 2019

Figure 17. North America Nuclear Medicine/Radiopharmaceuticals Sales YoY Growth (2015-2025) (K Units)

Figure 18. North America Nuclear Medicine/Radiopharmaceuticals Revenue YoY Growth (2015-2025) (USD Million)

Figure 19. Europe Nuclear Medicine/Radiopharmaceuticals Sales YoY Growth (2015-2020) (K Units)

Figure 20. Europe Nuclear Medicine/Radiopharmaceuticals Revenue YoY Growth (2015-2020) (USD Million)

Figure 21. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales YoY Growth (2015-2020) (K Units)

Figure 22. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue YoY Growth (2015-2020) (USD Million)

Figure 23. South America Nuclear Medicine/Radiopharmaceuticals Sales YoY Growth (2015-2020) (K Units)

Figure 24. South America Nuclear Medicine/Radiopharmaceuticals Revenue YoY Growth (2015-2020) (USD Million)

Figure 25. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Sales YoY Growth (2015-2020) (K Units)

Figure 26. Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Revenue YoY Growth (2015-2020) (USD Million)

Figure 27. North America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019

Figure 28. North America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019

Figure 29. United States Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate (2015-2025) (USD Million)

Figure 30. Canada Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate (2015-2025) (USD Million)

Figure 31. Mexico Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate (2015-2020) (USD Million)

Figure 32. Europe Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019

Figure 33. Germany Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 34. United Kingdom Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 35. France Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 36. Russia Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 37. Italy Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 38. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Region 2018

Figure 39. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Region 2018

Figure 40. China Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 41. Japan Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 42. Korea Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 43. India Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 44. Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 45. Australia Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 46. South America Nuclear Medicine/Radiopharmaceuticals Sales Market Share by Country in 2019

Figure 47. South America Nuclear Medicine/Radiopharmaceuticals Revenue Market Share by Country in 2019

Figure 48. Brazil Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 49. Argentina Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 50. Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 51. Turkey Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 52. Egypt Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 53. South Africa Nuclear Medicine/Radiopharmaceuticals Market Size Growth Rate (2015-2025) (USD Million)

Figure 54. Global Revenue Market Share of Nuclear Medicine/Radiopharmaceuticals by Type in 2019

Figure 55. Global Revenue Market Share of Nuclear Medicine/Radiopharmaceuticals by Application in 2019

Figure 56. Sales Channel: Direct Channel vs Indirect Channel